11 Community CCRx SM PDP 2010 Plan Year – Stakeholder Call Speakers: Marc Bralts, Vice President,...
-
Upload
imogen-linda-casey -
Category
Documents
-
view
216 -
download
0
Transcript of 11 Community CCRx SM PDP 2010 Plan Year – Stakeholder Call Speakers: Marc Bralts, Vice President,...
11
Community CCRxSM PDP2010 Plan Year – Stakeholder Call
Speakers:
Marc Bralts, Vice President, Network OperationsMichael Bukach, RPh, Senior V.P. Pharmacy Network and Clinical OperationsAmber Jones, RPh, Sr. Manager, Pharmacy Relations
2
Topics for Today’s Program
• Overall 2010 Medicare Part D Changes
• 2010 Bid Results
• 2010 PDP Plan Design
• MA-PD Overview
• 2010 Formulary Update
• 2010 MTM Program
• Agent-Pharmacy Partnership Program
• CMS Compliance & Community CCRxSM Tools
3
Medicare Part D Updates
• Annual bidding continues to drive change each plan year.
• Nationally, there are approximately 800k auto-assigned duals being moved due to plans missing the benchmark.
– “choosers” will not be automatically reassigned• They can choose to switch plans or pay the difference (between plan
premium and benchmark)
• Part D members being moved will be notified via: – ANOC – late October– Letter notifying them of reassignment for upcoming year
4
Community CCRx Bid Results
• Remained under LIS benchmark for 2010 in every current region with the exception of New Mexico
• States back under LIS benchmark for 2010:– MA, RI, VT, CT, UT, ID
• States new under benchmark for 2010: – AZ, NV
• Merging of PDPs to conclude in 2012– PrescribaRxSM Platinum (PDP) Community CCRxSM Gold (PDP) in 2010
5
Gold• $0 deductible• Copays (30-day supply)
– Generics: $6– Preferred Brand:
$35– Non-Preferred
Brand: $65– Specialty: 33%
• Gap Coverage: Generic Tier Drugs Only
Choice• $150 deductible• Copays (30-day supply)
– Generics: $5– Preferred Brand:
$35– Non-Preferred
Brand: $65– Specialty: 29%
• No Gap Coverage
Basic• $310 deductible• Copays (30-day supply)
– Generics: $0– Preferred Brand :
25-30%– Non-Preferred
Brand: 50-75%– No specialty
• No Gap Coverage
2010 Plan Design Changes
6
Agent Program
• Agent Partnership for 2010 selling season– Additional training to improve field results
– In-store agent opportunities (pending agent availability in certain regions)
– Strong support from 800# call-center• Highly trained, fully-licensed agents• Available for all stores
7
Pharmacy Education Kits
• Education kits should arrive by 10/1
• Kits include: – Pre-enrollment packets - Formulary flyer– Cover letter with CMS guidelines - Tear sheets– Town Hall flyer - Plan Comparison Guide– Calendar with Marketing dates
• Request a Pharmacy Education kit or additional pre-enrollment packets:
– Email: [email protected]– Call: 866-684-3057– Online at: (www.mhrx.com)
8
2010 Formulary Update: Tier Changes
Actos, ActoPlus Met, Duetact Aromasin Asacol Hectorol Invega Pentasa Sanctura, Sanctura XR VESIcare
Tier Changes
9
2010 Formulary Update: Deletions
Deletion Alternative
Prevacid Solutab omeprazole (G), Nexium Oral Packets (PB), Zegerid Oral Packets (PB)
Aciphex omeprazole (G), Nexium (PB)
Amitiza lactulose (G)
Ranitidine Caps ranitidine tabs (G)
Catapres-TTS Patches any oral antihypertensive
Atacand, Atacand HCT Cozaar, Hyzaar, Diovan, Diovan HCT (PB)
Asmanex Flovent, Pulmicort Flexhaler, QVAR (PB)
Rhinocort Aqua Fluticasoen (G), Nasonex (PB), Vermayst (PB)
Oxytrol Detrol, Detrol LA, Toviaz, Enablex (PB)
Nitrolingual Nitrostat (NPB)
Antara fenofibrate (G), Tricor (PB), Trilipix (PB)
Deletion Alternative
10
2010 Formulary Update: Deletions (Beers List)
Deletion Alternative
Diphenhydramine caps/tabs fexofenadine (G), Xyzal (NPB)
Meperidine tablets acetaminophen with codeine (G), acetaminophen with hydrocodone (G), morphine (G)
Butalbital-ASA-Caffeine-Codeine acetaminophen with codeine (G), acetaminophen with hydrocodone (G)
Meprobamate buspirone, sertraline
Pentazocine-Naloxone acetaminophenwith codeine (G), acetaminophen with hydrocodone (G)
Deletion Alternative
11
2010 Formulary Update: Step Therapy
– VESIcare – Actos, Actos PlusMet, Duetact – Abilify, Invega – AVINza – BuPROPion HCl & – Budeprion XL 24-hr ER tablets
– Aromasin, Femara
Step Therapy
View formulary alternatives and step therapy criteria at:
www.mhrx.com/providers
12
Formulary Updates
• Group Plans move from Alliance and Alliance Plus formularies to Optimal Med formulary – starting 1/1/2010.
• Communication– Member
• Formulary change letters• ANOC• EOB
– Pharmacist • Fax
13
2010 Updates
• Payer Sheet – no significant changes– “Prescription Origin” code
• Mail Order – no mail order for Community CCRx in 2010
• 2010 Incentive Program– MTM – new eligibility criteria
14
Medicare Advantage Prescription Drug Plans (MA-PD)
• Private Fee-For-Service (PFFS)• Preferred Provider Organizations (PPO)• Health Maintenance Organizations (HMO)• Most Universal American MA-PD plans are “powered by
CCRx” drug benefit
• Extended enrollment period through March 31st.• Online: www.UniversalAmerican.com
15
Fraud, Waste and Abuse
• CMS Regulation• Attestation is not required• Conducted in 2009 calendar year
– Universal American Part D Fraud, Waste and Abuse training module
– Alternative Training Programs must address specific topics at a minimum
16
Alternative Training Requirements
• Compliance with Federal statutes (i.e., False Claims Act, Anti-Kickback Statute, HIPAA, etc.)
• Requirement to have appropriate policies and procedures to address fraud, waste and abuse
• Types of fraud, waste and abuse that can occur, including but not limited to:• Inappropriate billing practices• Bait and switch pricing• Prescription altering• Dispensing expired or altered prescription drugs• Illegal remuneration• True Out of Pocket (TrOOP) manipulation
• Incorrect or misleading notices to employees• U.S. Office of Inspector General (OIG) exclusion list• Process for reporting fraud, waste and abuse• Protections in non retaliation for employees who report suspected fraud,
waste and abuse
17
Providers Can:
Distribute CMS- approved Plan Finder information. Display promotional materials that announce your relationship with a plan. Make available printed information provided by a plan sponsor to your
patients, as long as there is no “ranking,” “highlighting” or comparison of specific plans.
Provide contact information for any plan which a beneficiary expresses an interest and requests such contact information from you.
Make available PDP marketing materials and enrollment applications. Use direct mail and/or e-mail to announce a new plan affiliation Provide information and assistance to your patients in applying for the low
income subsidy.
For additional information, see the Medicare Marketing Guidelines, available at: http://www.cms.hhs.gov/ManagedCareMarketing/Downloads/R91MCM.pdf
18
Providers Cannot
Direct, urge, persuade, steer or offer inducements to join a particular plan. Compare plan benefits against other health plans, unless the materials were written or
approved by CMS Make available PDP enrollment forms at the counter. Collect or accept Medicare enrollment applications of any kind. Offer sales or appointment forms. Mail marketing materials on behalf of a plan. Make available third party sales or plan promotional materials that are not CMS -
approved. Expect or accept compensation for conducting enrollment or marketing activities. Suggest that a particular plan is approved, endorsed or authorized by Medicare. Make or distribute plan information, including PDP enrollment forms, during health
screenings.
For additional information, see the Medicare Marketing Guidelines, available at: http://www.cms.hhs.gov/ManagedCareMarketing/Downloads/R91MCM.pdf
19
Tools and Resources
• Website: www.mhrx.com 2010 Formularies
60 Day Formulary Notices
Drug Search Tool Fraud Waste and Abuse Module PA Forms PA Criteria PA Status Search Pharmacy Scorecard
20
2010 Part D: Community CCRx
Thank You for your continued Support.
Questions & Answers